4DMedical Limited operates as a software technology company in Australia. It commercializes XV Technology, a four-dimensional lung imaging platform that utilizes proven and patented mathematic models and algorithms to convert X-ray scans into quantitative data to enhance the capacity of physicians to manage patients with respiratory diseases and diseases of the lung. The company is also developing VQ (Perfusion), a diagnostic to scan and measure both ventilation and perfusion; and CFPA (Vasculature), a novel and non-invasive imaging technique that provides regional measurements of the pulmonary vasculature, as well as small animal ventilators and preclinical scanners. 4DMedical Limited was founded in 2012 and is based in Melbourne, Australia.